News

Merck also introduces the first perioperative anti-PD-1 treatment regimen for adults with resectable locally advanced head ...
The collaboration aims to advance the discovery and development of novel oral candidates.
Mitsubishi Research Institute and Astellas have agreed on a memorandum of understanding to provide drug-discovery startups in ...
TekniPlex Healthcare has commenced production activities at its new 200,000-square-foot facility in Madison, Wisconsin.
The research program will combine Debiopharm’s AbYlink conjugation technology with Alkyon’s modular antibody platform and ...
Nuvation Bio Inc., a global oncology company, received U.S. Food and Drug Administration (FDA) approval of Ibtrozi ...
Cryoport Inc. has completed the previously announced divestiture of its specialty courier business, CRYOPDP, to DHL Group.
Novo Nordisk and Deep Apple Therapeutics Inc. have entered a research collaboration and exclusive license agreement.
Over the past decade, the emergence of advanced therapy medicinal products (ATMPs) has fundamentally changed the approach to ...
OncoACP3 is a small molecule ligand with high affinity and specificity for Acid Phosphatase 3 (ACP3), a novel target in ...
How the effectiveness, flexibility and sustainability of single-use technologies solve many of today’s challenges in ...
According to Fortune Business Insights, the global contract research organization (CRO) services market size was valued at ...